Episode 11: The FDA Finally Woke Up About Estrogen — But Women Are Still Left Deficient

After twenty years of fear-based medicine, the FDA has finally woken up about estrogen (sort of) — admitting that the black box warning never should have existed.

It’s validation, yes. But it’s also frustrating. Because while the FDA finally corrected the label, they didn’t correct the hormone restoration system. Women are still being prescribed low-dose, symptom-management therapies that leave them hormonally deficient, mentally foggy, and physically depleted. Basically, estrogen-starved.

I’ve been teaching for years that estrogen was never the problem — the problem was targeted misinformation, fear, and a deliberate standard of care designed to keep women in need of more estrogen.

In this episode, my producer and co-host, Maggie Kuhn, and I break down what the FDA got right, what they ignored, and why this moment — while historic — still falls short of real progress for women’s health.

If you want to understand the difference between managing menopause and full hormone restoration, this is the episode to listen to.

What You’ll Learn:

• Why the FDA finally reversed the 2003 black box warning
• The truth about the Women’s Health Initiative study and decades of misinformation
• How estrogen protects the brain, heart, bones, and lifespan
• Why women are still not receiving full hormone restoration
• What needs to change in medical education and practice for women to get real results

Disclaimer

The views expressed on the Me.No.Pause Moxie Podcast are based on over twenty years of clinical observation, research, education, training, and personal experience by Clinical Hormone Coach Marie Hoäg, MBA. This content is for educational, informational, and entertainment purposes only and is not intended as medical or hormone therapy advice. Always consult a trained HRT professional before making any hormone-balancing decisions.

Remember, everybody benefits when YOUR hormones are balanced.